Search results
Aspect wins $72.75m from Canadian government for bioprinted pipeline
Medical Device Network· 3 days agoAspect’s tissue therapeutic platform is said to combine the company’s bioprinting technology,...
Eli Lilly weight loss drug beats Ozempic in head-to-head study - ET HealthWorld | Pharma
The Economic Times· 5 days agoWashington: Patients taking Eli Lilly's new drug Mounjaro achieved significantly greater weight loss...
Gerresheimer core profit meets forecast on weight-loss drug deals pipeline - ETPharma
The Economic Times· 3 days agoGerresheimer: The packaging and medical equipment maker's deals with weight loss drugs makers, such...
‘Compounded’ weight-loss drugs are a growing problem for state regulators
Washington State Standard· 5 days agoAnna Wysock’s “aha” moment arrived in an Ohio amusement park, as she got ready to ride a roller...
Gerresheimer core profit meets forecast on weight-loss drug deals pipeline - ET HealthWorld | Pharma
The Economic Times· 3 days agoGerresheimer: The packaging and medical equipment maker's deals with weight loss drugs makers, such...
Amylyx to rebuild pipeline with $35m Phase III ready GLP-1RA acquisition
Clinical Trials Arena· 4 days agoNo trials have been conducted in either type 2 diabetes (T2D) or obesity where the field of GLP-1RAs...
Pfizer moves forward with once-daily weight loss pill
CNBC Awaaz· 3 days agoThe Pfizer drug is part of the second-generation of weight loss pills, under development by...
Torrent Pharma. Summary: Latest Updates and Details | India Infoline
India Infoline· 5 days agoTorrent Pharmaceuticals Limited, the flagship Company of the Torrent Group, is one of the leading pharmaceutical companies having presence in Indian and global markets. The Company is a dominant ...
Flagship raises $3.6B for biotech investing
BioPharma Dive· 4 days agoThat division leads partnerships with major industry players including Pfizer, Novo Nordisk and the Cystic Fibrosis Foundation. While Flagship can point...
Impact of AI on metabolic disorder clinical trials
Clinical Trials Arena· 3 days agoThe use of AI in metabolic disorders research began increasing in 2023. Obesity and T2D research have been the focus of research since the development of...
